Ameritas Investment Partners’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,010
| Closed | -$13K | – | 3100 |
|
|
2022
Q1 | $13K | Hold |
5,010
| – | – | ﹤0.01% | 2707 |
|
|
2021
Q4 | $22K | Hold |
5,010
| – | – | ﹤0.01% | 2596 |
|
|
2021
Q3 | $26K | Hold |
5,010
| – | – | ﹤0.01% | 2555 |
|
|
2021
Q2 | $32K | Hold |
5,010
| – | – | ﹤0.01% | 2464 |
|
|
2021
Q1 | $39K | Buy |
5,010
+1,321
| +36% | +$10.3K | ﹤0.01% | 2229 |
|
|
2020
Q4 | $24K | Hold |
3,689
| – | – | ﹤0.01% | 2377 |
|
|
2020
Q3 | $25K | Hold |
3,689
| – | – | ﹤0.01% | 2257 |
|
|
2020
Q2 | $31K | Hold |
3,689
| – | – | ﹤0.01% | 2106 |
|
|
2020
Q1 | $28K | Hold |
3,689
| – | – | ﹤0.01% | 1982 |
|
|
2019
Q4 | $31K | Hold |
3,689
| – | – | ﹤0.01% | 2175 |
|
|
2019
Q3 | $27K | Hold |
3,689
| – | – | ﹤0.01% | 2224 |
|
|
2019
Q2 | $41K | Hold |
3,689
| – | – | ﹤0.01% | 2018 |
|
|
2019
Q1 | $40K | Buy |
3,689
+450
| +14% | +$4.88K | ﹤0.01% | 2011 |
|
|
2018
Q4 | $49K | Hold |
3,239
| – | – | ﹤0.01% | 1818 |
|
|
2018
Q3 | $60K | Hold |
3,239
| – | – | ﹤0.01% | 1883 |
|
|
2018
Q2 | $74K | Buy |
3,239
+689
| +27% | +$15.7K | ﹤0.01% | 1742 |
|
|
2018
Q1 | $73K | Hold |
2,550
| – | – | ﹤0.01% | 1691 |
|
|
2017
Q4 | $54K | Hold |
2,550
| – | – | ﹤0.01% | 1884 |
|
|
2017
Q3 | $44K | Hold |
2,550
| – | – | ﹤0.01% | 1968 |
|
|
2017
Q2 | $40K | Buy |
2,550
+959
| +60% | +$15K | ﹤0.01% | 2049 |
|
|
2017
Q1 | $27K | Buy |
+1,591
| New | +$27K | ﹤0.01% | 2226 |
|